Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Three Medications to Treat Diarrhea in Adults.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female at least 18 years of age~* Acute diarrhea illness with symptoms onset within 48 hours of study entry~* Minimum of 3 unformed stools in 24 hours before study entry~* Most recent stool is unformed~* Abdominal discomfort/wind (intensity mild to severe) within 4 hours of study entry~* Women of childbearing potential must have a negative pregnancy test at screening~* Willing to adhere to the prohibitions and restrictions specified in this protocol~* Subjects must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study~Exclusion Criteria:~* Requiring hospital admission, parenteral hydration or antibiotic therapy Axillary temperature \>38.2°C or oral temperature \>38.6°C~* History or clinical evidence of gross blood or pus in stool in current illness~* Signs or symptoms of orthostatic hypotension~* Unable to take medication and fluids by mouth~* History of chronic gastrointestinal disease, hepatic or renal insufficiency, or other significant medical condition that could be aggravated by untreated acute diarrhea~* Immunodeficiency (e.g. those with acquired immunodeficiency syndrome \[AIDS\] or known human immunodeficiency virus \[HIV\] infection, or undergoing chemotherapy or radiotherapy)~* Intake of antibiotics, oral antifungals, quinidine or ritonavir within 7 days, antidiarrhoeal, promotility drugs (e.g., metoclopramide, domperidone), antiflatulents (e.g., simeticone, activated charcoal) or probiotics or bismuth salts within 48 hours, or any analgesic within 6 hours prior to study entry Hypersensitivity to loperamide, yeast, or any component of study formulations~* Pregnant or breast-feeding~* Unable to comply with the protocol requirements and schedule~* Any condition that, in the opinion of the investigator, would compromise the well-being of the subject or the study~* Use of opiates (as 'recreational' drugs and as painkillers)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Loperamide/simeticone Caplets (Type: EXPERIMENTAL): Drug (including placebo)
- Loperamide/simeticone Chewable Tablets (Type: ACTIVE_COMPARATOR): Drug (including placebo)
- Probiotic Capsules (Type: ACTIVE_COMPARATOR): Drug (including placebo)

Based on this trial design, predict the completion outcome and termination type (if applicable).